Federated Hermes, Inc. Akebia Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 868,021 shares of AKBA stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

868,021

Previous 865,252 0.32%

Holding current value

$1.55 Million

Previous $882,000 29.82%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.94 - $1.55 $2,602 - $4,291	2,769 Added 0.32%	868,021 $1.15 Million
Q2 2024 Aug 08, 2024	SELL	$0.86 - $1.63 $1,119 - $2,122	-1,302 Reduced 0.15%	865,252 $882,000
Q4 2023 Jan 31, 2024	SELL	$0.8 - $1.28 $78,911 - $126,257	-98,639 Reduced 10.22%	866,554 $1.07 Million
Q2 2023 Aug 14, 2023	SELL	$0.51 - $1.43 $27,967 - $78,419	-54,839 Reduced 5.38%	965,193 $887,000
Q4 2022 Feb 13, 2023	SELL	$0.25 - $0.58 $195,126 - $452,692	-780,504 Reduced 43.35%	1,020,032 $591,000
Q3 2022 Nov 14, 2022	SELL	$0.3 - $0.46 $56,679 - $86,908	-188,931 Reduced 9.5%	1,800,536 $569,000
Q2 2022 Aug 15, 2022	SELL	$0.32 - $0.67 $12,975 - $27,167	-40,548 Reduced 2.0%	1,989,467 $702,000
Q1 2022 May 13, 2022	SELL	$0.72 - $2.93 $3,119 - $12,692	-4,332 Reduced 0.21%	2,030,015 $1.46 Million
Q4 2021 Feb 14, 2022	BUY	$2.26 - $3.34 $11,851 - $17,514	5,244 Added 0.26%	2,034,347 $4.6 Million
Q3 2021 Nov 15, 2021	BUY	$2.35 - $3.88 $341,518 - $563,868	145,327 Added 7.71%	2,029,103 $5.84 Million
Q2 2021 Aug 16, 2021	BUY	$2.83 - $4.2 $5.33 Million - $7.91 Million	1,882,252 Added 123507.35%	1,883,776 $7.14 Million
Q4 2020 Feb 12, 2021	SELL	$2.22 - $3.78 $687,749 - $1.17 Million	-309,797 Reduced 99.51%	1,524 $4,000
Q3 2020 Nov 12, 2020	BUY	$2.39 - $13.08 $91,685 - $501,774	38,362 Added 14.05%	311,321 $781,000
Q2 2020 Aug 13, 2020	BUY	$6.67 - $13.58 $1.82 Million - $3.71 Million	272,959 New	272,959 $3.71 Million
Q4 2019 Feb 14, 2020	SELL	$3.16 - $6.73 $21,453 - $45,689	-6,789 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.55 - $5.4 $1,842 - $2,802	519 Added 8.28%	6,789 $27,000
Q2 2019 Aug 14, 2019	SELL	$4.1 - $8.05 $5,059 - $9,933	-1,234 Reduced 16.44%	6,270 $30,000
Q1 2019 May 10, 2019	SELL	$5.41 - $8.73 $3,689 - $5,953	-682 Reduced 8.33%	7,504 $61,000
Q4 2018 Feb 13, 2019	SELL	$5.39 - $9.15 $10,068 - $17,092	-1,868 Reduced 18.58%	8,186 $45,000
Q3 2018 Nov 13, 2018	BUY	$7.44 - $10.65 $72,398 - $103,635	9,731 Added 3012.69%	10,054 $89,000
Q2 2018 Aug 10, 2018	BUY	$9.15 - $11.34 $384 - $476	42 Added 14.95%	323 $3,000
Q1 2018 May 09, 2018	BUY	$9.53 - $15.68 $142 - $235	15 Added 5.64%	281 $3,000
Q4 2017 Feb 14, 2018	SELL	$14.24 - $19.59 $3,574 - $4,917	-251 Reduced 48.55%	266 $0
Q3 2017 Nov 13, 2017	BUY	$13.06 - $19.67 $6,752 - $10,169	517	517 $10,000

Others Institutions Holding AKBA

# of Institutions

121

Shares Held

54.8M

Call Options Held

291K

Put Options Held

179K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $329M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Akebia Therapeutics, Inc. Transaction History